Develops oxygen delivery technologies and solutions for medical applications, aiming to enhance patient care and respiratory therapy.
Inspira Technologies Oxy B.H.N. Ltd., based in Ra'anana, Israel, is a specialized medical device company dedicated to advancing respiratory support technology as a non-invasive alternative to traditional mechanical ventilation (MV) for managing respiratory failure. At the forefront of its offerings is the augmented respiration technology system (ART), a revolutionary solution that features a portable dual lumen cannula inserted into the jugular vein. This system utilizes extra-corporeal direct blood oxygenation to effectively elevate and stabilize declining oxygen saturation levels, catering to patients requiring intensive respiratory care.
Formerly known as Insense Medical Ltd., the company rebranded as Inspira Technologies Oxy B.H.N. Ltd. in July 2020 to reflect its expanded focus and commitment to innovation in respiratory therapy. Founded in 2018, Inspira Technologies combines cutting-edge research, development, and manufacturing capabilities to address critical healthcare challenges, particularly in the field of respiratory medicine. The company's mission centers on enhancing patient outcomes through advanced medical technologies that offer more effective and less invasive treatment options.
Inspira Technologies Oxy B.H.N. Ltd. operates with a vision to transform respiratory care by pioneering minimally invasive solutions that improve patient comfort and clinical outcomes. With a growing presence in the global healthcare market, the company continues to innovate and expand its portfolio of respiratory support systems, striving to set new standards in respiratory therapy and critical care management.